Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007232
Filing Date
2019-08-06
Accepted
2019-08-06 16:09:23
Documents
62
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q c842-20190630x10q.htm 10-Q 2329204
2 EX-10.1 c842-20190630ex101837ada.htm EX-10.1 201663
3 EX-31.1 c842-20190630ex31199832d.htm EX-31.1 17795
4 EX-31.2 c842-20190630ex312bf933d.htm EX-31.2 17783
5 EX-32.1 c842-20190630ex3219d894b.htm EX-32.1 9423
6 GRAPHIC c84220190630x10q001.jpg GRAPHIC 80893
  Complete submission text file 0001558370-19-007232.txt   7347674

Data Files

Seq Description Document Type Size
7 EX-101.INS c842-20190630.xml EX-101.INS 1528459
8 EX-101.SCH c842-20190630.xsd EX-101.SCH 42778
9 EX-101.CAL c842-20190630_cal.xml EX-101.CAL 46236
10 EX-101.DEF c842-20190630_def.xml EX-101.DEF 132808
11 EX-101.LAB c842-20190630_lab.xml EX-101.LAB 372948
12 EX-101.PRE c842-20190630_pre.xml EX-101.PRE 260304
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 191002149
SIC: 2834 Pharmaceutical Preparations